Back to search

Article

Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions

2022-06-28

Abstract excerpt

<title>Abstract</title> <p>Precision oncology programs can rapidly identify oncogenic gene fusions in individual patients<sup>1–3</sup>. However, despite their established oncogenic status, the vast majority of gene fusions remain ‘<italic>undruggable</italic>’ due to the lack of specific inhibitory molecules<sup>4,5</sup>. Here, we establish <italic>Psp</italic>Cas13b, a poorly characterized programmable RNA nuc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f2de634-45e1-588d-8421-fcf21bfa4a4d
DOI
10.21203/rs.3.rs-1714034/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusionsDOI 10.21203/rs.3.rs-1714034/v1
Select a neighboring publication to make it the new centre.